Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of quadrivalent versus trivalent influenza vaccine in children
2010-021032-34Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Fluarix and influenza vaccine (split virion, inactivated) in influenza (3 arms), sponsored by GSK. Primary endpoints: Humoral immune response in terms of HI antibodies, Immunological non-inferiority of D-QIV versus TIV-1 and TIV-2 and 1 more. Started Jul 2010; status: completed.
02
Drugs
Fluarixinfluenza vaccine (split virion, inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-021032-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021032-34.